Literature DB >> 8590606

A computer modeling postulated mechanism for angiotensin II receptor activation.

M P Joseph1, B Maigret, J C Bonnafous, J Marie, H A Scheraga.   

Abstract

The angiotensin II receptor of the AT1-type has been modeled starting from the experimentally determined three-dimensional structure of bacteriorhodopsin as the template. Intermediate 3D structures of rhodopsin and beta 2-adrenergic receptors were built because no direct sequence alignment is possible between the AT1 receptor and bacteriorhodopsin. Docking calculations were carried out on the complex of the modeled receptor with AII, and the results were used to analyze the binding possibilities of DuP753-type antagonistic non-peptide ligands. We confirm that the positively charged Lys199 on helix 5 is crucial for ligand binding, as in our model; the charged side chain of this amino acid interacts strongly with the C-terminal carboxyl group of peptide agonists or with the acidic group at the 2'-position of the biphenyl moiety of DuP753-type antagonists. Several other receptor residues which are implicated in the binding of ligands and the activation of receptor by agonists are identified, and their functional role is discussed. Therefore, a plausible mechanism of receptor activation is proposed. The three-dimensional docking model integrates most of the available experimental observations and helps to plan pertinent site-directed mutagenesis experiments which in turn may validate or modify the present model and the proposed mechanism of receptor activation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8590606     DOI: 10.1007/bf01886795

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  65 in total

1.  Modeling of G-protein-coupled receptors: application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors.

Authors:  S Trumpp-Kallmeyer; J Hoflack; A Bruinvels; M Hibert
Journal:  J Med Chem       Date:  1992-09-18       Impact factor: 7.446

2.  Strength and co-operativity of contributions of surface salt bridges to protein stability.

Authors:  A Horovitz; L Serrano; B Avron; M Bycroft; A R Fersht
Journal:  J Mol Biol       Date:  1990-12-20       Impact factor: 5.469

3.  Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin.

Authors:  R A Dixon; B K Kobilka; D J Strader; J L Benovic; H G Dohlman; T Frielle; M A Bolanowski; C D Bennett; E Rands; R E Diehl; R A Mumford; E E Slater; I S Sigal; M G Caron; R J Lefkowitz; C D Strader
Journal:  Nature       Date:  1986 May 1-7       Impact factor: 49.962

4.  Helical peptides with three pairs of Asp-Arg and Glu-Arg residues in different orientations and spacings.

Authors:  B M Huyghues-Despointes; J M Scholtz; R L Baldwin
Journal:  Protein Sci       Date:  1993-01       Impact factor: 6.725

Review 5.  Adrenoceptors and their second messenger systems.

Authors:  R J Summers; L R McMartin
Journal:  J Neurochem       Date:  1993-01       Impact factor: 5.372

Review 6.  This is not a G protein-coupled receptor.

Authors:  M F Hibert; S Trumpp-Kallmeyer; J Hoflack; A Bruinvels
Journal:  Trends Pharmacol Sci       Date:  1993-01       Impact factor: 14.819

7.  Modeling of G-protein coupled receptors with bacteriorhodopsin as a template. A novel approach based on interaction energy differences.

Authors:  D Röper; E Jacoby; P Krüger; M Engels; J Grötzinger; A Wollmer; W Strassburger
Journal:  J Recept Res       Date:  1994-05

8.  Aromatic-aromatic interactions and protein stability. Investigation by double-mutant cycles.

Authors:  L Serrano; M Bycroft; A R Fersht
Journal:  J Mol Biol       Date:  1991-03-20       Impact factor: 5.469

9.  Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy.

Authors:  R Henderson; J M Baldwin; T A Ceska; F Zemlin; E Beckmann; K H Downing
Journal:  J Mol Biol       Date:  1990-06-20       Impact factor: 5.469

10.  The (i, i + 4) Phe-His interaction studied in an alanine-based alpha-helix.

Authors:  K M Armstrong; R Fairman; R L Baldwin
Journal:  J Mol Biol       Date:  1993-03-05       Impact factor: 5.469

View more
  10 in total

Review 1.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

Review 2.  Modes of peptide binding in G protein-coupled receptors.

Authors:  M Berthold; T Bartfai
Journal:  Neurochem Res       Date:  1997-08       Impact factor: 3.996

3.  Critical hydrogen bond formation for activation of the angiotensin II type 1 receptor.

Authors:  Jérôme Cabana; Brian Holleran; Marie-Ève Beaulieu; Richard Leduc; Emanuel Escher; Gaétan Guillemette; Pierre Lavigne
Journal:  J Biol Chem       Date:  2012-12-07       Impact factor: 5.157

4.  N-glycosylation requirements for the AT1a angiotensin II receptor delivery to the plasma membrane.

Authors:  B Deslauriers; C Ponce; C Lombard; R Larguier; J C Bonnafous; J Marie
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

5.  Use of small angle neutron scattering to study the interaction of angiotensin II with model membranes.

Authors:  Julia Preu; Timo Jaeger; Vasil M Garamus; Thomas Gutberlet
Journal:  Eur Biophys J       Date:  2011-02-03       Impact factor: 1.733

6.  Model of the whole rat AT1 receptor and the ligand-binding site.

Authors:  Camelia Baleanu-Gogonea; Sadashiva Karnik
Journal:  J Mol Model       Date:  2006-01-11       Impact factor: 1.810

7.  The fifth transmembrane domain of angiotensin II Type 1 receptor participates in the formation of the ligand-binding pocket and undergoes a counterclockwise rotation upon receptor activation.

Authors:  Ivana Domazet; Stéphane S Martin; Brian J Holleran; Marie-Eve Morin; Patrick Lacasse; Pierre Lavigne; Emanuel Escher; Richard Leduc; Gaétan Guillemette
Journal:  J Biol Chem       Date:  2009-09-22       Impact factor: 5.157

8.  Analysis of transmembrane domains 1 and 4 of the human angiotensin II AT1 receptor by cysteine-scanning mutagenesis.

Authors:  Liping Yan; Brian J Holleran; Pierre Lavigne; Emanuel Escher; Gaétan Guillemette; Richard Leduc
Journal:  J Biol Chem       Date:  2009-11-23       Impact factor: 5.157

9.  The second transmembrane domain of the human type 1 angiotensin II receptor participates in the formation of the ligand binding pocket and undergoes integral pivoting movement during the process of receptor activation.

Authors:  Ivana Domazet; Brian J Holleran; Stéphane S Martin; Pierre Lavigne; Richard Leduc; Emanuel Escher; Gaétan Guillemette
Journal:  J Biol Chem       Date:  2009-03-09       Impact factor: 5.157

10.  Receptor residence time trumps drug-likeness and oral bioavailability in determining efficacy of complement C5a antagonists.

Authors:  Vernon Seow; Junxian Lim; Adam J Cotterell; Mei-Kwan Yau; Weijun Xu; Rink-Jan Lohman; W Mei Kok; Martin J Stoermer; Matthew J Sweet; Robert C Reid; Jacky Y Suen; David P Fairlie
Journal:  Sci Rep       Date:  2016-04-20       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.